Collaborations

HCEMM-SU Molecular Oncohematology Research Group

Home > Teams > Genomic Instability and Cancer > HCEMM – SU Molecular Oncohematology Research Group > Collaborations

Collaborations

Jude Fitzgibbon, Barts Cancer Institute, London, UK
Christoph Bock, CEMM, Vienna, Austria
Frederick Damm, Charite, Berlin, Germany
MRC Holland, Amsterdam, The Netherlands.
Nanostring, Seattle, USA
Epizyme, Cambridge, USA

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.

Awards

Consortium

About HCEMM

Hungarian Centre of Excellence for Molecular Medicine is a strong catalyst of reformative changes in biomedical science and in institutional research management.

National VAT number: 26307383-2-06
EU VAT number: HU26307383

Internal Policies

Contact Info

Copyright © 2024 Hungarian Centre of Excellence for Molecular Medicine, all rights reserved. Hungarian Centre of Excellence for Molecular Medicine® and HCEMM® are registered trademarks of the the HCEMM Nonprofit Ltd.